Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in
addition to amphotericin B products, to our armamentarium against mucormycosis, many …

Although not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility
testing (AFST) is a tool of increasing importance in clinical microbiology laboratories. The …

The order Mucorales, which includes the agents of mucormycosis, comprises a large
number of species. These fungi are characterised by high-level resistance to most currently …

Mucormycosis is an uncommon, yet deadly invasive fungal infection caused by the
Mucorales moulds. These pathogens are a WHO-assigned high-priority pathogen group, as …

Systemic antifungal agents are increasingly used for prevention or treatment of invasive
fungal infections, whose prognosis remains poor. At the same time, emergence of resistant …

Mucormycoses are emerging and potentially lethal infections. An increase of breakthrough
infections has been found in cohorts receiving short-tailed azoles prophylaxis (eg …

Mucormycosis is a fungal infection which got worsens with time if not diagnosed and treated.
The current COVID-19 pandemic has association with fungal infection specifically with …

Antifungal susceptibility testing is an important tool for managing patients with invasive
fungal infections, as well as for epidemiological surveillance of emerging resistance. For …

The emergence of Mucorales infections is an urgent global public health threat rapidly
disseminating during the current COVID-19 pandemic. Invasive mucormycosis carries …

Abstract The World Health Organization, in response to the growing burden of fungal
disease, established a process to develop a fungal priority pathogens list (FPPL). This …